MDMA is known for its popularity in the rave and music festival scene, but doctors are testing whether or not the potent empathy-inducing drug can treat alcohol addiction. Preliminary results of the first study of this kind currently show promising results.
According to the Guardian, doctors in Bristol are testing whether some doses of MDMA, colloquially referred to as Molly, in conjunction with psychotherapy to help people overcome a condition could make alcohol dependence more effective than traditional treatments. Only one patient who completed the study for the study is relapsed, which is above average for the treatment of alcoholism. In England, on average, eight out of ten relapses within three years of traditional therapy.
"We have one person who has relapsed completely, returned to the previous drinking levels, we have five persons who are completely dry, and we have four or five who drank a drink or two, but the diagnosis of one Have not reached alcoholic disorder, "said Dr. Ben Sessa, addiction psychiatrist and senior research associate at Imperial College London, who led the study, the Guardian. "With the best medicine can do, 80% of people drink alcohol detox within three years."
Sessa said that this may be partly due to the ability of MDMA to interfere with a patient's anxiety response. This is helpful because it allows a person to remember a childhood trauma without fear of remembering it.
In the next phase of the study, research will continue to prove that MDMA combined with psychotherapy may be a resource for the treatment of alcoholism. Using a randomized control group, some patients are given a placebo instead of MDMA.
For the study, patients were given a medical and a psychological test, followed by an eight-week psychotherapy. In weeks three and six, they received MDMA in a hospital where both a psychiatrist and a psychologist were present. These sessions last about eight hours, and most of the participants are lying down with their glasses and headphones on.
"We let them direct the sessions wherever they want. What comes out does not depend on the clinicians, "said Sessa.
After the session, patients stay overnight and call once a day for the following week to collect data on sleep, mood, and potential suicidal risk.
"There is no black Monday, no blue Tuesday or whatever Raver calls it. In my opinion, this is an artefact of swarming. It's not about MDMA, "Sessa said. "If there were a lot of people abusing cancer chemotherapy, you would not think, 'Oh, it's not safe to take cancer chemo if doctors give it to you."
Sessa added, "Scientists I know it's not dangerous, the Sun newspaper thinks it's dangerous because the tiny number of deaths that occur each year end up on their front page."
MDMA was experiencing A Medical Comeback Recently, US experimental therapists tested psychotherapy sessions from 1
A number of studies have been undertaken to support the use of MDMA in therapeutic situations, particularly in the environment, to improve the efficacy of the treatment of post-traumatic stress disorder (PTSD), according to a British journal, The Lancet Psychiatry, in the year For example, in 2018 published study revealed that after two sessions with MDMA-Psychothera In a majority of 26 veterans and first responders with chronic PTSD, there was a decrease in symptoms.
MDMA research is often unaffordable, especially in the United States, where medical research on MDMA is legally limited. MDMA has been a List 1 drug in the US since 1986, although there was a surge of interest in declassifying it for therapeutic reasons. Recently, non-profit organizations such as the Multidisciplinary Association for Psychedelic Studies (MAPS) have been working to change their legal status.